Dolutegravir Tablet for Oral Suspension
RxNorm 2374561

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2374561 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dolutegravir Tablet for Oral Suspension.

The following semantic concepts and normalized strings are associated with this clinical entity:

Type (TTY)

Clinical Name / Synonym

Atom ID

Details

SCDF

Dolutegravir Tablet for Oral Suspension

AUI:12407117 

View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

Semantic Clinical Drug Form (SCDF):
Dolutegravir Tablet for Oral Suspension
(Atom ID: 12407117)

Clinical Status & Identity

Prescribable Status

YES (Active)

Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.

Concept Description

dolutegravir Tablet for Oral Suspension

Official description of the drug concept as defined in the source vocabulary.

Suppress Flag

N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)

2374561

RxNorm Unique Identifier for the standardized concept.

Atom ID (RXAUI)

12407117

Unique identifier for this specific name variation (Atom).

Term Type (TTY)

SCDF

Semantic Clinical Drug Form (Ingredient + Dose Form)

Source Code

2374561

The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name

RxNorm Vocabulary (RXNORM)

The official name and abbreviation for the vocabulary source.

Source Version

20AA_260601F

The specific version of the vocabulary provided by the source.

Update Date

June 01, 2026

The date when this RxNorm data was last updated by the NLM.

License Contact

RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/

Source licensing contact information.

Patient Education

Dolutegravir

Dolutegravir is used with other medications to treat human immunodeficiency virus (HIV) infection in adults and children 4 weeks of age and older who weigh at least 6.6 lbs (3 kg). It is also used in combination with rilpivirine (Edurant) to treat HIV in certain adults to replace their current HIV medication(s) that has been taken for at least 6 months. Dolutegravir is in a class of medications called HIV integrase inhibitors. It works by decreasing the amount of HIV in your blood and increasing the number of immune cells that help fight infections in your body. Although dolutegravir does not cure HIV, using it along with other medications may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
[Learn More]

* Please review the disclaimer below.